Endothelial Nitric Oxide synthase (eNOS) in Preeclampsia: An Update

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Genetics

Background:

• Preeclampsia (PE) is a major cause of maternal and infant mortality, with increasing incidence and healthcare costs in the US.
• PE poses long-term health risks, including cardiovascular and cerebrovascular diseases, for both mother and child.
• Current treatments for PE are lacking, and its underlying causes remain largely unknown.

Purpose of the Study:

• To review studies investigating the role of endothelial nitric oxide synthase (eNOS) in preeclampsia.
• To explore the potential of manipulating the eNOS/NO pathway for preeclampsia intervention.

Main Methods:

• Review of human epidemiological studies linking genetic factors, specifically eNOS variants, to PE.
• Analysis of animal experimental studies demonstrating a functional connection between eNOS and PE.
• Synthesis of research on eNOS/NO pathway modulation for disease intervention.

Main Results:

• Human studies indicate an association between eNOS gene variants and preeclampsia.
• Animal studies provide evidence for a functional role of eNOS in PE development.
• The eNOS/NO pathway is implicated as a potential therapeutic target for PE.

Conclusions:

• Endothelial nitric oxide synthase (eNOS) plays a significant role in preeclampsia.
• Targeting the eNOS/NO pathway presents a promising avenue for future preeclampsia interventions.
• Further research into the genetic and functional aspects of eNOS in PE is warranted.